Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zynerba Pharmaceuticals

1.30
0.0000
Volume:- -
Turnover:1.13M
Market Cap:65.60M
PE:-1.62
High:1.30
Open:1.30
Low:1.30
Close:1.30
Loading ...
Mar 10, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Mar 10, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 26, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 25, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Dec 02, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Sep 24, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 18, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 30, 2019

Major Issues Report

Current report, items 1.01, 5.02, and 9.01
Aug 09, 2019

Correspondence

[Cover]Correspondence
Aug 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 06, 2019

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Jul 03, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities